Ernest Kun

3.9k total citations
113 papers, 2.7k citations indexed

About

Ernest Kun is a scholar working on Molecular Biology, Oncology and Clinical Biochemistry. According to data from OpenAlex, Ernest Kun has authored 113 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 38 papers in Oncology and 18 papers in Clinical Biochemistry. Recurrent topics in Ernest Kun's work include PARP inhibition in cancer therapy (35 papers), DNA Repair Mechanisms (18 papers) and Metabolism and Genetic Disorders (18 papers). Ernest Kun is often cited by papers focused on PARP inhibition in cancer therapy (35 papers), DNA Repair Mechanisms (18 papers) and Metabolism and Genetic Disorders (18 papers). Ernest Kun collaborates with scholars based in United States, Hungary and Germany. Ernest Kun's co-authors include E. Kirsten, Michael N. Berry, Kálman G. Büki, Pál I. Bauer, Alaeddin Hakam, Jerome Mendeleyev, Charles P. Ordahl, Walter N. Piper, D.W. Fanshier and Andrew L. Salzman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ernest Kun

112 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ernest Kun United States 28 1.5k 960 309 302 295 113 2.7k
Torsten Börchers Germany 29 2.0k 1.3× 409 0.4× 190 0.6× 319 1.1× 336 1.1× 48 2.8k
Irving Lieberman United States 41 3.2k 2.1× 464 0.5× 97 0.3× 387 1.3× 326 1.1× 91 4.7k
Juris Ozols United States 40 2.3k 1.6× 507 0.5× 428 1.4× 609 2.0× 257 0.9× 95 4.2k
W.E. Pricer United States 21 2.5k 1.7× 325 0.3× 211 0.7× 498 1.6× 406 1.4× 26 3.7k
É. Kun United States 24 864 0.6× 487 0.5× 146 0.5× 155 0.5× 128 0.4× 57 1.5k
R. Coleman United Kingdom 42 2.3k 1.5× 2.0k 2.1× 107 0.3× 380 1.3× 654 2.2× 142 5.2k
Lawrence M. Ballas United States 24 2.2k 1.5× 243 0.3× 223 0.7× 395 1.3× 226 0.8× 37 3.5k
Albert Breier Slovakia 27 1.4k 0.9× 869 0.9× 125 0.4× 139 0.5× 167 0.6× 140 2.4k
Kou‐Yi Tserng United States 27 1.1k 0.8× 333 0.3× 176 0.6× 153 0.5× 521 1.8× 74 2.4k
David B. Rhoads United States 31 1.8k 1.2× 414 0.4× 90 0.3× 239 0.8× 443 1.5× 66 3.5k

Countries citing papers authored by Ernest Kun

Since Specialization
Citations

This map shows the geographic impact of Ernest Kun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernest Kun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernest Kun more than expected).

Fields of papers citing papers by Ernest Kun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernest Kun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernest Kun. The network helps show where Ernest Kun may publish in the future.

Co-authorship network of co-authors of Ernest Kun

This figure shows the co-authorship network connecting the top 25 collaborators of Ernest Kun. A scholar is included among the top collaborators of Ernest Kun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernest Kun. Ernest Kun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kun, Ernest, E. Kirsten, Alaeddin Hakam, Pál I. Bauer, & Jerome Mendeleyev. (2008). Dependence of trans‐ADP‐ribosylation and nuclear glycolysis on the Arg 34–ATP complex of Zn2+ finger I of poly‐ADP‐ribose polymerase‐1. FEBS Letters. 582(18). 2709–2713. 1 indexed citations
2.
3.
Bauer, Pál I., István Kenessey, Kálman G. Büki, et al.. (2001). Molecular interactions between poly(ADP‐ribose) polymerase (PARP I) and topoisomerase I (Topo I): identification of topology of binding. FEBS Letters. 506(3). 239–242. 39 indexed citations
4.
Mihalik, Rudolf, Paul Bauer, Péter Krajcsi, et al.. (1999). Interaction of cytocidal drugs and the inhibition of caspase-3 by 3-nitrosobenzamide. International Journal of Cancer. 82(6). 875–879. 5 indexed citations
5.
Endres, Matthias, Gwen S. Scott, Andrew L. Salzman, et al.. (1998). Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development. European Journal of Pharmacology. 351(3). 377–382. 40 indexed citations
6.
Büki, Kálman G., Pál I. Bauer, & Ernest Kun. (1997). Isolation and identification of a proteinase from calf thymus that cleaves poly(ADP-ribose) polymerase and histone H1. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1338(1). 100–106. 19 indexed citations
7.
Bauer, Pál I., et al.. (1994). Phosphorylation of poly(ADP-ribose)polymerase protein in human peripheral lymphocytes stimulated with phytohemagglutinin. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1223(2). 234–239. 7 indexed citations
8.
Cole, Gerald A., Gerhard Bauer, E. Kirsten, et al.. (1991). Inhibition of HIV-1 IIIb replication in AA-2 and NT-2 cells in culture by two ligands of poly (ADP-ribose) polymerase: 6-amino-1,2-benzopyrone and 5-iodo-6-amino-1,2-benzopyrone. Biochemical and Biophysical Research Communications. 180(2). 504–514. 22 indexed citations
9.
Büki, Kálman G., et al.. (1989). Binding of adenosine diphosphoribosyltransferase to the termini and internal regions of linear DNAs. Biochemistry. 28(13). 5670–5680. 42 indexed citations
10.
Milo, George E., Steven M. D’Ambrosio, & Ernest Kun. (1989). Benzamide prevention of ultraviolet radiation‐induced transformation as measured by anchorage‐independent growth and the absence of correlation with thymidine dimer formation and DNA repair. Teratogenesis Carcinogenesis and Mutagenesis. 9(3). 167–176. 1 indexed citations
11.
Bánfalvi, Gáspár, János Szöllõsi, E. Kirsten, et al.. (1989). Cellular regulation of ADP-ribosylation of proteins. Experimental Cell Research. 184(1). 44–52. 9 indexed citations
12.
Büki, Kálman G. & Ernest Kun. (1988). Polypeptide domains of ADP-ribosyltransferase obtained by digestion with plasmin. Biochemistry. 27(16). 5990–5995. 27 indexed citations
13.
Kun, Ernest. (1982). Monofluoroacetic acid (Compound 1080), its pharmacology and toxicology. Proceedings - Vertebrate Pest Conference. 10(10). 17269–17269. 4 indexed citations
14.
Kirsten, E., Manohar Sharma, & Ernest Kun. (1979). Molecular Toxicology of (-)-erythro-Fluorocitrate: Selective Inhibition of Citrate Transport in Mitochondria and the Binding of Fluorocitrate to Mitochondrial Proteins. Molecular Pharmacology. 16(2). 686–686. 41 indexed citations
15.
Kirsten, E., Manohar Sharma, & Ernest Kun. (1978). Molecular Toxicology of (-)-erythro-Fluorocitrate: Selective Inhibition of Citrate Transport in Mitochondria and the Binding of Fluorocitrate to Mitochondria1 Proteins. Molecular Pharmacology. 14(1). 172–184. 13 indexed citations
16.
Kun, Ernest, et al.. (1974). Inhibition of Liver Aconitase Isozymes by (-)-erythro-Fluorocitrate. Molecular Pharmacology. 10(1). 130–139. 20 indexed citations
17.
Kun, Ernest & Santiago Grisolı́a. (1972). Biochemical regulatory mechanisms in eukaryotic cells. Wiley-Interscience eBooks. 17 indexed citations
18.
Kun, Ernest, Pierre Volfin, & Horace H. Loh. (1967). Studies with Specific Enzyme Inhibitors. Molecular Pharmacology. 3(6). 497–502. 1 indexed citations
19.
Ayling, June E. & Ernest Kun. (1965). Studies with specific enzyme inhibitors. X. Mechanism of action of L-(+)-beta-monofluorlactate on crystalline heart muscle lactate dehydrogenase.. PubMed. 1(3). 255–65. 7 indexed citations
20.
Ayling, June E. & Ernest Kun. (1965). Studies with Specific Enzyme Inhibitors. Molecular Pharmacology. 1(3). 255–265. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Torsten Börchers Breakdown of academic impact, for papers by Irving Lieberman Breakdown of academic impact, for papers by Juris Ozols Breakdown of academic impact, for papers by W.E. Pricer Breakdown of academic impact, for papers by É. Kun Breakdown of academic impact, for papers by R. Coleman Breakdown of academic impact, for papers by Lawrence M. Ballas Breakdown of academic impact, for papers by Albert Breier Breakdown of academic impact, for papers by Kou‐Yi Tserng Breakdown of academic impact, for papers by David B. Rhoads
Rankless by CCL
2026